CIPRA.ai
PrivateLast Round
Accelerator
Sep 1, 2025
Total Funding Raised
$1.22M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
CIPRA.ai operates in Healthcare & Life Sciences and is based in San Diego, California. Its latest recorded funding round was an Accelerator round in September 2025.
CIPRA.ai is a healthcare technology company that has developed a healthcare management software platform designed to support chronic disease care through individualized modeling and continuous monitoring.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Patient Engagement, Health IoT
Business Model
B2B2C
Customer Profile
Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CIPRA.ai Comparables
Compare CIPRA.ai with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Center Health | 84% | |
| Thrive AI Health | 80% | |
| Welldoc | 78% |
For institutional investors. Book with your work email.
CIPRA.ai Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Sep 1, 2025 | ||||
| Seed | Sep 12, 2023 |
For institutional investors. Book with your work email.
CIPRA.ai Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Techstars | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 10, 2026
Open roles increased to 5, 2.5x the trailing average.
- Jul 28, 2026
Monthly visitors grew 75% MoM.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- is_developingSep 22, 2026
On Sep 22nd '26, CIPRA.ai partners with Murata to develop AI-powered medical wearables that combine advanced sensors with a digital twin platform to turn live physiological data into personalized, predictive insights for proactive chronic disease monitoring.
- partners_withSep 21, 2026
CIPRA.ai and Murata Manufacturing Co. announce a collaboration in California on Sep 21st '26 to explore developing next-generation AI-powered wearable solutions for chronic disease management, including continuous health monitoring and personalized AI insights.
For institutional investors. Book with your work email.
CIPRA.ai Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about CIPRA.ai's valuation, stock price, and market status.
Is CIPRA.ai a public or private company?
CIPRA.ai is a private company.
What is the current stock price of CIPRA.ai?
CIPRA.ai is a private company, so its shares have no public market price. Caplight tracks CIPRA.ai's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is CIPRA.ai worth (valuation)?
Valuation information for CIPRA.ai is not publicly available.
Can I buy CIPRA.ai stock?
CIPRA.ai shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was CIPRA.ai's last funding round?
CIPRA.ai's most recent funding round was Accelerator on September 1, 2025.
Who are the main investors in CIPRA.ai?
Key investors in CIPRA.ai include Techstars.
Will CIPRA.ai IPO soon?
No public IPO plans have been announced for CIPRA.ai.
How can I track CIPRA.ai secondary market activity?
Caplight tracks bids, offers, and trades in CIPRA.ai's shares on secondary markets.